How Much Does It Cost to Add Vitals Monitoring to a Device?

Anyone scoping a hardware roadmap eventually hits the same procurement question: what is the real cost to add vitals monitoring to a device, and does it make financial sense to build the capability internally or license it? The honest answer is that the sticker price of a camera and a chip is the smallest line item in the budget. The expensive parts are the signal-processing engine, the validation work, and the regulatory documentation that turn a video feed into a defensible vital sign. For medical device companies, kiosk manufacturers, and IoT platform providers, understanding how those costs stack up is the difference between a feature that ships and a prototype that stalls in engineering review.

The global contactless vital signs monitoring market was valued at roughly USD 1.3 billion in 2024 and is projected to reach USD 4.5 billion by 2035, a compound annual growth rate near 12.3 percent, according to Business Research Insights (2024).

That growth is exactly why so many device teams are pricing this capability now. The opportunity is real, but so is the spend required to capture it.

Breaking down the cost to add vitals monitoring to a device

The cost to add vitals monitoring to a device falls into three buckets that behave very differently. Hardware is mostly fixed and predictable. Software is where the engineering risk concentrates. Integration and compliance is the bucket that teams routinely underestimate by the widest margin.

For camera-based, or remote photoplethysmography (rPPG), vitals, the hardware burden is unusually light. The technique reads tiny color changes in skin caused by blood flow, so most of the work happens in software rather than in dedicated sensors. That shifts the economics. Instead of paying a per-unit bill of materials premium for a cuff, an optical pulse sensor, and the mechanical assembly around them, the dominant cost moves into the algorithm and the data pipeline.

Industry cost surveys give a useful frame. Medical device software development for high-compliance systems typically runs from USD 150,000 to USD 250,000 or more for a focused module, and realistic end-to-end programs range from about USD 250,000 for a Class A minimum viable product to over USD 2 million for a Class C device, per estimates compiled across medical software development analyses in 2024. Adherence to IEC 62304, ISO 13485, and ISO 14971 alone tends to inflate development cost by 30 to 50 percent.

Here is how the two paths compare at a planning level.

Cost Component	Build In-House (camera-based vitals)	License an Embedded rPPG Engine
Core signal-processing R&D	USD 250k to 2M+, 12 to 24 months	Included in license fee
Specialist hiring (CV, DSP, ML)	3 to 6 senior engineers, recurring salary	Not required
Hardware bill of materials	Standard camera, no exotic sensors	Standard camera, no exotic sensors
Validation and test datasets	Built from scratch, high cost	Provided or shared by vendor
Regulatory documentation (IEC 62304)	Full burden on your team	Pre-prepared artifacts to inherit
Time to first integrated prototype	9 to 18 months	Weeks to a few months
Ongoing maintenance and updates	Internal team owns indefinitely	Bundled into licensing
Pricing model	Large fixed capex up front	Per-unit, per-seat, or annual license

The table makes the core tradeoff visible. Building gives you maximum control and no recurring license fee, but you carry the full weight of R&D, hiring, validation, and lifetime maintenance. Licensing converts a large and uncertain capital project into a predictable operating expense, and it compresses time to market dramatically.

Where the money actually goes

When teams audit their embedded vitals monitoring cost after the fact, the surprises cluster in a few predictable places.

• Signal processing, not optics. The camera is cheap. The engine that rejects motion artifacts and lighting changes is where most engineering hours disappear.
• Validation data. Collecting and labeling a demographically diverse dataset across skin tones, ages, and lighting conditions is slow and expensive, and it is non-negotiable for credibility.
• Regulatory artifacts. IEC 62304 software lifecycle documentation, risk files, and traceability matrices can consume as much effort as the code itself.
• Edge optimization. Getting a model to run in real time on an embedded processor rather than a cloud GPU is its own project, with its own cost.
• Maintenance tail. Algorithms drift, operating systems update, and security patches are mandatory. That recurring spend rarely appears in the original quote.

For contactless vitals device integration pricing specifically, the variable that swings budgets most is whether the vitals run on the edge or in the cloud. Edge processing raises upfront engineering cost but lowers per-unit operating cost and sidesteps bandwidth and privacy complications.

Industry applications and their cost profiles

Different deployments carry different cost sensitivities, which changes the build-versus-license math.

Clinical Kiosks

Clinical kiosks demand the highest validation and documentation rigor, which pushes in-house build costs toward the top of the range. Because these units ship in moderate volumes at higher price points, the per-unit cost of a camera health sensor licensing arrangement is easy to absorb, and the inherited regulatory artifacts shorten the path to deployment.

Iot and smart displays

IoT platform providers usually ship at high volume and thin margins. Here, per-unit license fees matter enormously, and the conversation centers on efficient edge processing to avoid recurring cloud costs. A lightweight embedded engine that runs on existing silicon protects the bill of materials.

Tablet and Hardware OEMs

For OEMs adding vitals as a differentiator across a product line, the appeal of licensing is amortization. One integration effort spreads across many SKUs, and the embedded vitals monitoring cost becomes a known per-device figure rather than a multi-year R&D gamble.

Current research and evidence

The case for camera-based vitals rests on a maturing body of validation work, which also explains why the software, not the hardware, commands the budget. A 2023 clinical validation of rPPG-enabled contactless pulse rate monitoring software in cardiovascular disease patients reported a mean absolute error of about 1.06 beats per minute for pulse rate, with a Pearson correlation of 0.962 against ECG, published in PMC. Separate work on a non-contact photoplethysmography mobile application reported a heart rate mean absolute error of 2.96 beats per minute, as documented in a study indexed on PubMed (2023).

Comprehensive reviews of rPPG and deep learning note that top-performing algorithms on benchmark datasets have reached mean absolute error below 2 beats per minute under controlled conditions, while flagging motion and lighting as the persistent real-world challenges, per a review in PMC (2023). The practical takeaway for a cost model is direct: accuracy is a function of algorithm quality and validation depth, which is precisely the expensive part to reproduce internally and the part a mature licensed engine has already paid down.

The future of vitals monitoring costs

Several forces are pushing the cost curve in favor of integration over ground-up building. Edge AI hardware keeps getting cheaper and more capable, which lowers the optimization burden that once made embedded vitals a specialist project. Validation datasets are becoming more standardized, reducing the marginal cost of credibility. And as the market expands toward the multibillion-dollar figures the forecasts describe, licensing models are maturing into clearer per-unit and annual structures that procurement teams can model with confidence.

The likely endpoint is that vitals monitoring becomes a component decision rather than a research program, much as GPS, wireless modules, and biometric authentication did before it. Teams that treat it as a buildable platform feature, sourced from a proven engine, will reach market faster and at a more predictable cost than teams attempting to rebuild signal processing and regulatory documentation from zero.

Frequently asked questions

What is the typical cost to add vitals monitoring to a device? Building camera-based vitals in-house commonly ranges from about USD 250,000 for a simple compliant module to well over USD 2 million for a higher-risk class of device, driven mostly by software R&D, validation, and regulatory documentation rather than hardware. Licensing an embedded engine converts that into a per-unit or annual fee with a far shorter timeline.

Why is the software more expensive than the hardware? Camera-based, or rPPG, vitals use a standard camera and no exotic sensors, so the bill of materials stays low. The value and the cost sit in the algorithm that extracts a clean signal, the validation data that proves accuracy, and the IEC 62304 documentation, all of which are labor-intensive to produce.

Does building in-house ever make financial sense? It can for organizations with existing computer vision, DSP, and regulatory teams plus a long product horizon to amortize the investment. For most kiosk and IoT manufacturers, the recurring maintenance tail and time-to-market penalty make licensing the lower total-cost path.

How does deployment scale change the decision? High-volume, low-margin products are most sensitive to per-unit license fees and edge processing efficiency, while lower-volume, higher-value clinical hardware benefits most from inheriting validation and regulatory artifacts to shorten approval timelines.

Circadify is addressing this space with an embedded rPPG engine designed to drop into kiosks, tablets, smart displays, and clinical hardware without a multi-year internal build. Teams pricing a vitals feature can review the detailed cost and integration breakdown in the hardware integration guide at circadify.com/custom-builds/clinical-kiosks.